Patients with chronic obstructive bronchopathies (COBP) have significantly lower Antithrombin III (AT III) levels. This reduction in AT III may increase the risk of bleeding complications in COBP patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: